Table S4 from Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma
Authors:
- Glenn J. HannaGHGlenn J. Hanna
- Nicole ScarfoNSNicole Scarfo
- Kee-Young ShinKSKee-Young Shin
- Anne O’nEillAOAnne O’nEill
- Veronica BedardVBVeronica Bedard
- Michael J. DennisMDMichael J. Dennis
- Kartik SehgalKSKartik Sehgal
- Vickie Y. JoVJVickie Y. Jo
- Kristine WongKWKristine Wong
- Andrey UgolkovAUAndrey Ugolkov
- Andrew MazarAMAndrew Mazar
- Robert I. HaddadRHRobert I. Haddad
Open Access
- 6 January 2026
- other
- Published by American Association for Cancer Research (AACR)